Exelixis Inc Property, Plant and Equipment, Gross
Exelixis Inc (EXEL) had Property, Plant and Equipment, Gross of $231.19 million as of 2026-01-02, per its 10-K filed 2026-02-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-02-10
- 2026-01-02: Property, Plant and Equipment, Gross $231.19M.
- 2025-01-03: Property, Plant and Equipment, Gross $220.12M.
- 2023-12-29: Property, Plant and Equipment, Gross $209.12M.
- 2022-12-30: Property, Plant and Equipment, Gross $171.50M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2026-01-02 | $231.19M 10-K · filed 2026-02-10 |
| 2025-01-03 | $220.12M 10-K · filed 2026-02-10 |
| 2023-12-29 | $209.12M 10-K · filed 2025-02-11 |
| 2022-12-30 | $171.50M 10-K · filed 2024-02-06 |
| 2021-12-31 | $144.86M 10-K · filed 2023-02-07 |
| 2021-01-01 | $102.07M 10-K · filed 2022-02-18 |
| 2020-01-03 | $74.45M 10-K · filed 2021-02-11 |
| 2019-09-27 | $72.86M 10-Q · filed 2019-10-30 |
| 2019-06-28 | $72.02M 10-Q · filed 2019-07-31 |
| 2019-03-29 | $69.82M 10-Q · filed 2019-05-01 |
| 2018-12-28 | $68.21M 10-K · filed 2020-02-25 |
| 2018-09-28 | $66.90M 10-Q · filed 2018-11-01 |
| 2018-06-29 | $78.90M 10-Q · filed 2018-08-01 |
| 2018-03-30 | $68.58M 10-Q · filed 2018-05-02 |
| 2017-12-29 | $48.54M 10-K · filed 2019-02-22 |
| 2017-09-30 | $42.37M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $41.51M 10-Q · filed 2017-08-02 |
| 2016-12-31 | $26.95M 10-Q · filed 2017-11-01 |
| 2016-12-30 | $26.95M 10-K · filed 2018-02-26 |
| 2015-12-31 | $25.74M 10-K · filed 2017-02-27 |
| 2014-12-31 | $48.70M 10-K · filed 2016-02-29 |
| 2013-12-31 | $50.70M 10-K · filed 2015-03-02 |
| 2012-12-31 | $52.61M 10-K · filed 2014-02-20 |
| 2011-12-31 | $59.88M 10-K · filed 2013-02-21 |
| 2010-12-31 | $90.66M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |